Moughon DL - Search Results

1

CRISPR-Mediated VHL Knockout Generates an Improved Model for Metastatic Renal Cell Carcinoma.

Schokrpur S, Hu J, Moughon DL, Liu P, Lin LC, Hermann K, Mangul S, Guan W, Pellegrini M, Xu H, Wu L. Schokrpur S, et al. Among authors: moughon dl. Sci Rep. 2016 Jun 30;6:29032. doi: 10.1038/srep29032. Sci Rep. 2016. PMID: 27358011 Free PMC article.

2

Macrophage Blockade Using CSF1R Inhibitors Reverses the Vascular Leakage Underlying Malignant Ascites in Late-Stage Epithelial Ovarian Cancer.

Moughon DL, He H, Schokrpur S, Jiang ZK, Yaqoob M, David J, Lin C, Iruela-Arispe ML, Dorigo O, Wu L. Moughon DL, et al. Cancer Res. 2015 Nov 15;75(22):4742-52. doi: 10.1158/0008-5472.CAN-14-3373. Epub 2015 Oct 15. Cancer Res. 2015. PMID: 26471360 Free PMC article.

3

CSF1 receptor targeting in prostate cancer reverses macrophage-mediated resistance to androgen blockade therapy.

Escamilla J, Schokrpur S, Liu C, Priceman SJ, Moughon D, Jiang Z, Pouliot F, Magyar C, Sung JL, Xu J, Deng G, West BL, Bollag G, Fradet Y, Lacombe L, Jung ME, Huang J, Wu L. Escamilla J, et al. Cancer Res. 2015 Mar 15;75(6):950-62. doi: 10.1158/0008-5472.CAN-14-0992. Epub 2015 Mar 3. Cancer Res. 2015. PMID: 25736687 Free PMC article.

4

Rapamycin enhances adenovirus-mediated cancer imaging and therapy in pre-immunized murine hosts.

Jiang ZK, Johnson M, Moughon DL, Kuo J, Sato M, Wu L. Jiang ZK, et al. Among authors: moughon dl. PLoS One. 2013 Sep 2;8(9):e73650. doi: 10.1371/journal.pone.0073650. eCollection 2013. PLoS One. 2013. PMID: 24023896 Free PMC article.

5

Targeting distinct tumor-infiltrating myeloid cells by inhibiting CSF-1 receptor: combating tumor evasion of antiangiogenic therapy.

Priceman SJ, Sung JL, Shaposhnik Z, Burton JB, Torres-Collado AX, Moughon DL, Johnson M, Lusis AJ, Cohen DA, Iruela-Arispe ML, Wu L. Priceman SJ, et al. Among authors: moughon dl. Blood. 2010 Feb 18;115(7):1461-71. doi: 10.1182/blood-2009-08-237412. Epub 2009 Dec 11. Blood. 2010. PMID: 20008303 Free PMC article.

6

Immunosuppressive tumor-infiltrating myeloid cells mediate adaptive immune resistance via a PD-1/PD-L1 mechanism in glioblastoma.

Antonios JP, Soto H, Everson RG, Moughon D, Orpilla JR, Shin NP, Sedighim S, Treger J, Odesa S, Tucker A, Yong WH, Li G, Cloughesy TF, Liau LM, Prins RM. Antonios JP, et al. Neuro Oncol. 2017 Jun 1;19(6):796-807. doi: 10.1093/neuonc/now287. Neuro Oncol. 2017. PMID: 28115578 Free PMC article.

7

PD-1 blockade enhances the vaccination-induced immune response in glioma.

Antonios JP, Soto H, Everson RG, Orpilla J, Moughon D, Shin N, Sedighim S, Yong WH, Li G, Cloughesy TF, Liau LM, Prins RM. Antonios JP, et al. JCI Insight. 2016 Jul 7;1(10):e87059. doi: 10.1172/jci.insight.87059. JCI Insight. 2016. PMID: 27453950 Free PMC article.

8

Detection of immune responses after immunotherapy in glioblastoma using PET and MRI.

Antonios JP, Soto H, Everson RG, Moughon DL, Wang AC, Orpilla J, Radu C, Ellingson BM, Lee JT, Cloughesy T, Phelps ME, Czernin J, Liau LM, Prins RM. Antonios JP, et al. Among authors: moughon dl. Proc Natl Acad Sci U S A. 2017 Sep 19;114(38):10220-10225. doi: 10.1073/pnas.1706689114. Epub 2017 Sep 5. Proc Natl Acad Sci U S A. 2017. PMID: 28874539 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

8 results

Search Page